Éric Gervais, executive vice-president of Duchesnay Inc, a privately-held, specialty Canadian pharma company focusing on women’s health, charts the company’s successful growth over the past 25 years, the innovative portfolio of in-house and in-licensed products they offer, as well as their plans for international expansion.
Eric, you were Duchesnay’s first employee in 1992. What has kept you at Duchesnay for the past 25 years?
"Health Canada is the market approval body but at the end of the day, it is the people within their walls that approve the drugs."
